Cat. No. | Product Name / Activity |
---|---|
4701 | EC 144 |
High affinity, potent and selective Hsp90 inhibitor | |
4703 | 3-Deazaneplanocin A hydrochloride |
EZH2 histone methyltransferase inhibitor | |
4705 | Chetomin |
Blocks interaction of HIF-1α, HIF-2α and STAT2 with CBP/p300 | |
4706 | Borrelidin |
Antiangiogenic; inhibits threonyl-tRNA synthetase | |
4708 | TC LPA5 4 |
LPA5 receptor antagonist | |
4709 | RuBi GABA trimethylphosphine |
Caged GABA; inhibits neural activity | |
4710 | PF 06465469 |
Potent ITK inhibitor; also inhibits BTK | |
4711 | Hexa-D-arginine |
Furin inhibitor | |
4712 | Salmeterol xinafoate |
Long-acting β2 agonist; bronchodilator | |
4715 | JZL 195 |
Dual FAAH and MAGL inhibitor | |
4716 | A 967079 |
Selective TRPA1 channel blocker | |
4719 | VU 0463271 |
Potent and selective KCC2 inhibitor | |
4720 | Entacapone |
Potent COMT inhibitor; blocks α-synuclein aggregation | |
4723 | T2AA |
PCNA inhibitor | |
4724 | BTT 3033 |
Selective inhibitor of integrin α2β1 | |
4725 | Eptifibatide |
Glycoprotein IIb/IIIa inhibitor; inhibits platelet aggregation | |
4726 | CTA 056 |
ITK inhibitor | |
4727 | GS 6201 |
Selective A2B antagonist | |
4730 | PPY A |
Potent inhibitor of Abl T315l mutant and wild-type Abl kinases | |
4731 | KY 02111 |
Inhibits canonical Wnt signaling. Promotes differentiation of human ESCs and iPSCs into cardiomyocytes | |
4732 | ML 204 |
Selective TRPC4 inhibitor | |
4735 | Quetiapine hemifumarate |
5-HT2 antagonist; also D2 antagonist; atypical antipsychotic | |
4736 | WIN 18446 |
ALDH1A2 inhibitor | |
4737 | CDDO Im |
Nrf2 signaling activator | |
4741 | Gadolinium chloride |
Stretch-activated calcium channel blocker; calcium-sensing receptor agonist | |
4745 | LIMKi 3 |
Potent LIM kinase inhibitor; antitumor | |
4746 | ML SA1 |
Activator of TRPML channels | |
4748 | ML 221 |
Apelin antagonist | |
4750 | TC Mps1 12 |
Potent and selective Mps1 kinase inhibitor | |
4751 | FSLLRY-NH2 |
PAR2 peptide antagonist | |
4753 | AL 8697 |
Potent and selective p38α inhibitor | |
4754 | AK 7 |
Selective SIRT2 inhibitor; brain penetrant | |
4756 | COR 170 |
Selective CB2 receptor inverse agonist | |
4758 | Bromosporine |
Broad spectrum bromodomain inhibitor | |
4759 | G-36 |
Selective GPER antagonist | |
4763 | Pyridostatin pentahydrochloride |
Stabilizes G-quadruplexes; induces DNA damage and cell cycle arrest | |
4766 | SIB 1508Y maleate |
Potent agonist of α4β2, α2β4, α4β4 and α3β4 nACh receptors | |
4767 | WAY 316606 hydrochloride |
Secreted Frizzled-related protein-1 (sFRP-1) inhibitor; increases Wnt signaling | |
4773 | ESI 09 |
Epac inhibitor | |
4774 | BMS 536924 |
Dual IR/IGF1R inhibitor | |
4775 | SD 2590 hydrochloride |
Potent MMP inhibitor | |
4776 | BIRT 377 |
Potent negative allosteric modulator of LFA-1 | |
4777 | ML 277 |
Selective KV7.1 (KCNQ1) potassium channel activator; augments IKs current | |
4778 | BETP |
Positive allosteric modulator of GLP-1 receptors | |
4779 | GRI 977143 |
Selective LPA2 receptor non-lipid agonist | |
4780 | VUF 11207 fumarate |
Potent ACKR3 (CXCR7) agonist | |
4781 | ANA 12 |
TrkB receptor antagonist | |
4782 | Org 25543 hydrochloride |
Potent and selective GlyT2 inhibitor | |
4784 | Edaglitazone |
Potent and selective PPARγ agonist; antidiabetic | |
4786 | PD 0332991 isethionate |
Potent cdk4 and cdk6 inhibitor; brain penetrant | |
4788 | NS 11021 |
KCa1.1 (BK) channel activator | |
4791 | Candesartan |
AT1 antagonist | |
4793 | CE3F4 |
Noncompetitive Epac1 inhibitor | |
4795 | Galloflavin |
Lactate dehydrogenase inhibitor; impairs aerobic glycolysis | |
4796 | Escitalopram oxalate |
Selective serotonin reuptake inhibitor (SSRI) | |
4798 | (S)-Duloxetine hydrochloride |
Potent 5-HT and NA reuptake inhibitor (SNRI); also blocks dopamine reuptake |